Sacral Neuromodulation in Neurogenic Patients

Efficacy and Safety of Sacral Neuromodulation With InterStim II in Neurogenic Bladder and/or Bowel Patients

The goal of this observational study is to evaluate efficacy and safety of sacral neuromodulation in neurogenic patients compared to non-neurogenic (idiopathic) patients. [. The main question[s] it aims to answer are:

• determine efficacy and safety of the therapy in neurogenic patients.
• compare outcomes of the therapy to idiopathic patients.

If there is a comparison group: Researchers will compare the outcomes of the therapy between the neurogenic and non-neurogenic subset of patients.

Inclusion Criteria:

• Patients who underwent InterStim II advanced evaluation for approved indication

Exclusion Criteria:

• N/A